|
Thomas C. Wilder III served most recently as President of ev3's Neurovascular Division. From 2002 to 2006, he served as President and Chief Executive Officer of MicroTherapeutics Inc. (MTI), a publicly-held medical device company focused on neurovascular technologies. MTI was a majority-owned subsidiary of ev3 that was merged fully into ev3 in January 2006. From 1991 to 2002, Wilder served at Medtronic Inc., most recently as Vice President and General Manager of its endovascular stent grafts division. During his tenure at Medtronic, he also held a variety of positions at U.S. and international locations, including Hong Kong, Belgium and The Netherlands. Wilder earned a BA from Stanford University and a MM. from Northwestern University's Kellogg Graduate School of Management. | 